Antibiotics help control rotavirus infections and enhance antirotaviral immunity: Are you serious?

Journal of Infectious Diseases

Volumn 210, Issue 2, 2014, Pages 167-170

  Bartelt, Luther A ^a   Guerrant, Richard L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

antibiotics

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; METRONIDAZOLE; NEOMYCIN; NITAZOXANIDE; PROBIOTIC AGENT; VANCOMYCIN;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; BIFIDOBACTERIUM LONGUM; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; NONHUMAN; NOTE; POLIOMYELITIS; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; SACCHAROMYCES BOULARDII; TREATMENT DURATION; VIRUS ENTRY; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS VIABILITY;

ANTIBIOTICS; DIARRHEA; MICROBIOTA; ROTAVIRUS; VACCINE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, VIRAL; DIARRHEA; FEMALE; IMMUNITY, HUMORAL; MALE; ROTAVIRUS INFECTIONS;

EID: 84903978185     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu153     Document Type: Note

References (29)

1. Uchiyama R, Chassaing B, Zhang B, Gerwertz AT. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J Infect Dis 2014; 210: 171-82.
2. Kuss SK, Best GT, Etheredge CA, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011; 334:249-52.
3. LaFrazia S, Ciucci A, Arnoldi F, et al. Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation. J Virol 2013; 87:11096-106.
4. Rossignol JF, Abu-Zekry M, Hussein A, Santoro MG. Effect of nitazoxanide for treatment of severe rotavirus diarrhea: randomized double-blind placebo-controlled trial. Lancet 2006; 368:124-9. (Pubitemid 43994153)
5. Teran CG, Teran-Escalera CN, Villarroel P. Nitazoxandie vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int J Inf Dis 2009; 13:518-23.
6. Grandy G, Medina M, Soria R, Teran CG, Araya M. Probiotics in the treatment of acute rotavirus diarrhea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 2010; 10:253.
7. Hayes KS, Bancroft AJ, Goldrick M, Portsmouth C, Roberts IS, Grencis RK. Exploitation of the intestinal microbiota by the parasitic nematode Trichuris muris. Science 2010; 328:1391-4.
8. Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A 2011; 108:5354-9.
9. Abt MC, Osborne LC, Monticelli LA, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012; 37:158-70.
10. Lantier L, Drouet F, Guesdon W, et al. Poly(I:C)-Induced protection of neonatal mice against intestinal Cryptosporidium parvum infection requires an additional TLR5 signal provided by the gut flora. J Infect Dis 2014; 209:457-67.
11. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral DxRRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13:310-12.
12. Preidis GA, Saulnier DM, Blutt SE, et al. Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice. J Pediatr Gastroenterol Nutr 2012; 55:299-307.
13. Sartor RB. Therapeutic manipulation of the enteric microbiota in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterol 2004; 126:1620-33. (Pubitemid 38649878)
14. Li E, Hamm CM, Gulati AS, et al. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One 2012; 7:e26284.
15. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-41.
16. Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-98.
17. Kriegel MA, Sefik E, Hill JA,Wu HJ, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A 2011; 108:11548-53.
18. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4615-22.
19. Wu HJ, Ivanov II, Darce J, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32:815-27.
20. Woo PY, Tsoi HW, Wong LP, Leung HC, Yuen KY. Antibiotics modulate vaccineinduced humoral immune response. Clin Diagn Lab Immunol 1999; 6:832-7. (Pubitemid 29529974)
21. Surana NJ, Kasper DL. The yin yang of bacterial polysaccharides: Lessons learned from B. fragilis PSA. Immunol Rev 2012; 245: 13-26.
22. Pons MJ, Mosquito S, Gomes C, Del Valle LJ, Ochoa TJ, Ruiz J. Quinolone-resistant analysis in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru. Trans R Soc Trop Med Hyg 2014; 108:22-8.
23. Mathers AJ, Guerrant RL. Dissecting the evolutionary stealth of our flora against antibiotics. Trans R Soc Trop Med Hyg 2014; 108:121-2.
24. Ng KM, Ferreyra JA, Higginbottom SK, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013; 502:96-9.
25. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-3. (Pubitemid 46018512)
26. Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339:548-54.
27. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472:57-63.
28. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368:1575-84.
29. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620-5. (Pubitemid 351769307)